BIOCERES CROP SOLUTIONS CORP. Fee And Commission Expense
BIOCERES CROP SOLUTIONS CORP. (BIOX) reported Fee And Commission Expense of $3.21 million for the 12-month period ending 2025-06-30, per its 20-F filed 2025-11-10.
Financial Statements › Expense Statement › Operating Expenses
ifrs-full:FeeAndCommissionExpense · last filed 2025-11-10
- BIOCERES CROP SOLUTIONS CORP. fee and commission expense for the quarter ending 2024-12-31 was $1.15M, a 73.95% increase year-over-year.
- BIOCERES CROP SOLUTIONS CORP. fee and commission expense for the quarter ending 2024-09-30 was $1.10M, a 75.14% increase year-over-year.
- BIOCERES CROP SOLUTIONS CORP. fee and commission expense for the quarter ending 2024-06-30 was $946.35K, a 76.59% increase year-over-year.
- BIOCERES CROP SOLUTIONS CORP. fee and commission expense for the quarter ending 2024-03-31 was $511.78K, a 1.40% increase year-over-year.
| Period end | Fee And Commission Expense 3 month | Fee And Commission Expense 6 month | Fee And Commission Expense 9 month | Fee And Commission Expense 12 month |
|---|---|---|---|---|
| 2025-06-30 | $3.21M 20-F · filed 2025-11-10 | |||
| 2024-12-31 | $1.15M 6-K · filed 2025-02-28 | $2.25M 6-K · filed 2025-02-28 | $3.20M derived: sum of 3 quarters · filed 2025-11-10 | $3.71M derived: sum of 4 quarters · filed 2025-11-10 |
| 2024-09-30 | $1.10M 6-K · filed 2024-11-27 | $2.05M derived: sum of 2 quarters · filed 2025-11-10 | $2.56M derived: sum of 3 quarters · filed 2025-11-10 | $3.22M derived: sum of 4 quarters · filed 2025-11-10 |
| 2024-06-30 | $946.35K derived: 20-F 12 month − 6-K 9 month · filed 2025-11-10 | $1.46M derived: sum of 2 quarters · filed 2025-11-10 | $2.12M derived: sum of 3 quarters · filed 2025-11-10 | $2.75M 20-F · filed 2025-11-10 |
| 2024-03-31 | $511.78K derived: 6-K 9 month − 6-K 6 month · filed 2024-05-29 | $1.17M derived: sum of 2 quarters · filed 2025-02-28 | $1.80M 6-K · filed 2024-05-29 | $2.34M derived: sum of 4 quarters · filed 2025-11-10 |
| 2023-12-31 | $659.26K 6-K · filed 2025-02-28 | $1.29M 6-K · filed 2025-02-28 | $1.82M derived: sum of 3 quarters · filed 2025-11-10 | $2.33M derived: sum of 4 quarters · filed 2025-11-10 |
| 2023-09-30 | $629.55K 6-K · filed 2024-11-27 | $1.17M derived: sum of 2 quarters · filed 2025-11-10 | $1.67M derived: sum of 3 quarters · filed 2025-11-10 | $2.13M derived: sum of 4 quarters · filed 2025-11-10 |
| 2023-06-30 | $535.91K derived: 20-F 12 month − 6-K 9 month · filed 2025-11-10 | $1.04M derived: sum of 2 quarters · filed 2025-11-10 | $1.50M derived: sum of 3 quarters · filed 2025-11-10 | $2.56M 20-F · filed 2025-11-10 |
| 2023-03-31 | $504.70K derived: 6-K 9 month − 6-K 6 month · filed 2024-05-29 | $961.89K derived: sum of 2 quarters · filed 2024-05-29 | $2.02M 6-K · filed 2024-05-29 | $2.94M derived: sum of 4 quarters · filed 2024-10-30 |
| 2022-12-31 | $457.19K derived: 6-K 6 month − 6-K 3 month · filed 2024-02-28 | $1.52M 6-K · filed 2024-02-28 | $2.44M derived: sum of 3 quarters · filed 2024-10-30 | $3.58M derived: sum of 4 quarters · filed 2024-10-30 |
| 2022-09-30 | $1.06M 6-K · filed 2023-11-29 | $1.98M derived: sum of 2 quarters · filed 2024-10-30 | $3.13M derived: sum of 3 quarters · filed 2024-10-30 | |
| 2022-06-30 | $921.12K derived: 20-F 12 month − 6-K 9 month · filed 2024-10-30 | $2.07M derived: sum of 2 quarters · filed 2024-10-30 | $2.97M 20-F · filed 2024-10-30 | |
| 2022-03-31 | $1.14M derived: 6-K 9 month − 6-K 6 month · filed 2023-05-24 | $2.05M 6-K · filed 2023-05-24 | ||
| 2021-12-31 | $907.66K 6-K · filed 2023-02-28 | |||
| 2021-06-30 | $2.32M 20-F · filed 2023-11-14 | |||
| 2020-12-31 | $964.24K 6-K · filed 2022-02-25 | |||
| 2020-06-30 | $1.48M 20-F · filed 2022-10-28 | |||
| 2019-12-31 | $757.75K 6-K · filed 2021-02-26 | |||
| 2019-06-30 | $1.58M 20-F · filed 2021-10-29 | |||
| 2018-12-31 | $1.06M 6-K/A · filed 2020-03-17 | |||
| 2018-06-30 | $1.63M 20-F · filed 2020-10-21 | |||
| 2017-06-30 | $1.03M 20-F · filed 2019-10-24 | |||
| 2016-12-31 | $885.35K 20-F · filed 2019-10-24 |